# APP

## Overview
The amyloid precursor protein (APP) gene encodes a type-I transmembrane protein known as amyloid beta precursor protein, which is integral to various cellular processes, particularly in the nervous system. APP is involved in cell adhesion, synaptogenesis, and neurite outgrowth, functioning as a synaptic adhesion molecule that facilitates neuronal development and function (Zheng2006Theamyloidprecursorprotein:beyondamyloid; Muller2011Physiological). The protein's structure is characterized by multiple domains, including a growth-factor-like domain and a copper-binding domain, which contribute to its diverse roles in cellular signaling and interaction (Reinhard2005The; Coburger2014The). APP is also implicated in the pathogenesis of Alzheimer's disease, with mutations in the APP gene leading to altered amyloid-beta peptide production, a key factor in the formation of amyloid plaques (Hunter2017Understanding). The gene's involvement in neurodegenerative diseases underscores its clinical significance and the importance of understanding its biological functions and interactions.

## Structure
The amyloid precursor protein (APP) is a type-I transmembrane protein with a complex multi-domain structure. Its primary structure includes multiple isoforms, such as APP 695, APP 751, and APP 770, resulting from alternative splicing. APP 695 is neuron-specific, while APP 770 includes a Kunitz-type protease inhibitor (KPI) domain (Gralle2007Structure; Coburger2014The).

The secondary structure of APP features alpha-helices and beta-sheets. The N-terminal region contains a growth-factor-like domain (GFLD) with nine β-strands and one α-helix, stabilized by disulfide bridges, and a copper-binding domain (CuBD) with a tetrahedral copper-binding site (Reinhard2005The; Kaden2012The). The E2 domain consists of a triple-stranded antiparallel coiled coil with a central helix (Reinhard2005The).

APP's tertiary structure is characterized by an extended conformation with domains arranged like balls on a string. The ectodomain includes the E1 domain (comprising GFLD and CuBD), the acidic region (AcD), the E2 domain, and the juxtamembrane region (JMR) (Coburger2014The).

Quaternary structure involves dimerization, influenced by interactions with heparin and metal ions, which is important for APP's function as a synaptic cell adhesion molecule (Kaden2012The; Coburger2014The). APP undergoes post-translational modifications, including phosphorylation and glycosylation, which regulate its functions (Gralle2007Structure).

## Function
The amyloid precursor protein (APP) plays a crucial role in various cellular processes in healthy human cells. It is involved in cell adhesion, synaptogenesis, and neurite outgrowth, which are essential for neuronal development and function (Zheng2006Theamyloidprecursorprotein:beyondamyloid). APP functions as a synaptic adhesion molecule, similar to neurexins and neuroligins, promoting synaptic adhesion and facilitating synaptogenesis (Muller2011Physiological). The protein interacts with extracellular matrix components like heparin, collagen type I, and laminin, and forms dimers that enhance cell-cell adhesion (Muller2011Physiological).

APP is also involved in neural and synaptic trophic functions, promoting neurite outgrowth and synaptic density. The soluble fragment APPsα is particularly important in these processes, contributing to spatial memory and long-term potentiation (LTP) (Muller2011Physiological). APP's intracellular domain is involved in axonal transport and cell signaling, interacting with proteins such as Fe65 and Mint-1/X11a, which are crucial for APP dynamics and processing (Zheng2006Theamyloidprecursorprotein:beyondamyloid).

In addition, APP is implicated in the regulation of gliogenesis and neurogenesis through various signaling pathways, including Notch and Wnt, highlighting its role in maintaining cellular homeostasis and neuronal health (Coronel2023Amyloid).

## Clinical Significance
Mutations in the APP gene are associated with several neurodegenerative conditions, most notably Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA). In familial Alzheimer's disease (FAD), mutations in APP can lead to increased production of amyloid-beta (Aβ) peptides, particularly Aβ42, which are central to the formation of amyloid plaques, a hallmark of AD pathology (Hunter2017Understanding). Specific mutations, such as the Swedish KM670/671NL, result in elevated Aβ levels, contributing to early-onset AD (Hunter2017Understanding).

The Arctic APP mutation is unique in causing early-onset AD with typical clinical features, including cognitive decline and characteristic neuropathological changes, such as ring-like amyloid plaques (Basun2008Clinical). Other mutations, like the Flemish A692G, are linked to both AD and CAA, characterized by amyloid deposition in cerebral vessels, leading to hemorrhagic strokes (Grabowski2001Novel; Weggen2012Molecular).

The APP p.A673T mutation is protective, reducing Aβ levels and lowering AD risk (Hunter2017Understanding). Conversely, the A673V mutation is associated with AD only in the homozygous state, demonstrating a recessive inheritance pattern (Di2009A). APP duplications, as seen in some familial cases, can also lead to increased Aβ production and AD (Hooli2012Role). These genetic variations highlight the complex role of APP in neurodegenerative diseases.

## Interactions
The amyloid precursor protein (APP) is involved in a complex network of interactions with various proteins, playing significant roles in cellular processes and Alzheimer's disease pathogenesis. APP interacts with several proteins through its intracellular domain, particularly involving the YENPTY motif, which serves as a docking site for phosphotyrosine-binding domain (PTB) proteins such as Fe65, X11, JIP1, and Numb (Russo2005The). Phosphorylation of Tyr-682 on this motif creates a docking site for SH2-domain containing proteins like ShcA and Grb2, which are involved in cell signaling pathways (Russo2005The; Tamayev2009The).

APP also interacts with extracellular proteins, including contactins and integrins. It binds to contactin-1, contactin-2, and contactin-4, influencing amyloidogenic processing and axon-target matching (Pfundstein2022Amyloid). APP's interaction with integrins, such as β1-integrins, affects cellular attachment and signaling pathways (Pfundstein2022Amyloid).

In the brain, APP forms a tripartite complex with calsyntenins and X11L, and interacts with GPI-anchored proteins like contactin, Thy-1, and PrP (Bai2008The). These interactions highlight APP's role in cell adhesion, neuritogenesis, and cell survival, although a comprehensive model reconciling its physiological functions with its protein interactions remains elusive (Bai2008The).


## References


[1. (Hunter2017Understanding) S Hunter and C Brayne. Understanding the roles of mutations in the amyloid precursor protein in alzheimer disease. Molecular Psychiatry, 23(1):81–93, November 2017. URL: http://dx.doi.org/10.1038/mp.2017.218, doi:10.1038/mp.2017.218. This article has 66 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/mp.2017.218)

[2. (Gralle2007Structure) Matthias Gralle and Sérgio T. Ferreira. Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts. Progress in Neurobiology, 82(1):11–32, May 2007. URL: http://dx.doi.org/10.1016/j.pneurobio.2007.02.001, doi:10.1016/j.pneurobio.2007.02.001. This article has 126 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.pneurobio.2007.02.001)

[3. (Basun2008Clinical) Hans Basun, Nenad Bogdanovic, Martin Ingelsson, Ove Almkvist, Jan Näslund, Karin Axelman, Thomas D. Bird, David Nochlin, Gerard D. Schellenberg, Lars-Olof Wahlund, and Lars Lannfelt. Clinical and neuropathological features of the arctic app gene mutation causing early-onset alzheimer disease. Archives of Neurology, 65(4):499, April 2008. URL: http://dx.doi.org/10.1001/archneur.65.4.499, doi:10.1001/archneur.65.4.499. This article has 86 citations.](https://doi.org/10.1001/archneur.65.4.499)

[4. (Tamayev2009The) Robert Tamayev, Dawang Zhou, and Luciano D’Adamio. The interactome of the amyloid β precursor protein family members is shaped by phosphorylation of their intracellular domains. Molecular Neurodegeneration, July 2009. URL: http://dx.doi.org/10.1186/1750-1326-4-28, doi:10.1186/1750-1326-4-28. This article has 65 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/1750-1326-4-28)

[5. (Muller2011Physiological) U. C. Muller and H. Zheng. Physiological functions of app family proteins. Cold Spring Harbor Perspectives in Medicine, 2(2):a006288–a006288, December 2011. URL: http://dx.doi.org/10.1101/cshperspect.a006288, doi:10.1101/cshperspect.a006288. This article has 214 citations and is from a peer-reviewed journal.](https://doi.org/10.1101/cshperspect.a006288)

[6. (Weggen2012Molecular) Sascha Weggen and Dirk Beher. Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant alzheimer’s disease. Alzheimer’s Research &amp; Therapy, 4(2):9, 2012. URL: http://dx.doi.org/10.1186/alzrt107, doi:10.1186/alzrt107. This article has 135 citations.](https://doi.org/10.1186/alzrt107)

[7. (Pfundstein2022Amyloid) Grant Pfundstein, Alexander G. Nikonenko, and Vladimir Sytnyk. Amyloid precursor protein (app) and amyloid β (aβ) interact with cell adhesion molecules: implications in alzheimer’s disease and normal physiology. Frontiers in Cell and Developmental Biology, July 2022. URL: http://dx.doi.org/10.3389/fcell.2022.969547, doi:10.3389/fcell.2022.969547. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2022.969547)

[8. (Hooli2012Role) B.V. Hooli, G. Mohapatra, M. Mattheisen, A.R. Parrado, J.T. Roehr, Y. Shen, J.F. Gusella, R. Moir, A.J. Saunders, C. Lange, R.E. Tanzi, and L. Bertram. Role of common and rare app dna sequence variants in alzheimer disease. Neurology, 78(16):1250–1257, April 2012. URL: http://dx.doi.org/10.1212/WNL.0b013e3182515972, doi:10.1212/wnl.0b013e3182515972. This article has 98 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1212/WNL.0b013e3182515972)

[9. (Russo2005The) Claudio Russo, Valentina Venezia, Emanuela Repetto, Mario Nizzari, Elisabetta Violani, Pia Carlo, and Gennaro Schettini. The amyloid precursor protein and its network of interacting proteins: physiological and pathological implications. Brain Research Reviews, 48(2):257–264, April 2005. URL: http://dx.doi.org/10.1016/j.brainresrev.2004.12.016, doi:10.1016/j.brainresrev.2004.12.016. This article has 53 citations.](https://doi.org/10.1016/j.brainresrev.2004.12.016)

[10. (Coronel2023Amyloid) Raquel Coronel, Adela Bernabeu-Zornoza, Charlotte Palmer, Rosa González-Sastre, Andreea Rosca, Patricia Mateos-Martínez, Victoria López-Alonso, and Isabel Liste. Amyloid precursor protein (app) regulates gliogenesis and neurogenesis of human neural stem cells by several signaling pathways. International Journal of Molecular Sciences, 24(16):12964, August 2023. URL: http://dx.doi.org/10.3390/ijms241612964, doi:10.3390/ijms241612964. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms241612964)

[11. (Bai2008The) Yu Bai, Kelly Markham, Fusheng Chen, Rasanjala Weerasekera, Joel Watts, Patrick Horne, Yosuke Wakutani, Rick Bagshaw, Paul M. Mathews, Paul E. Fraser, David Westaway, Peter St. George-Hyslop, and Gerold Schmitt-Ulms. The in vivo brain interactome of the amyloid precursor protein. Molecular &amp; Cellular Proteomics, 7(1):15–34, January 2008. URL: http://dx.doi.org/10.1074/mcp.M700077-MCP200, doi:10.1074/mcp.m700077-mcp200. This article has 209 citations.](https://doi.org/10.1074/mcp.M700077-MCP200)

[12. (Kaden2012The) Daniela Kaden, Lisa Marie Munter, Bernd Reif, and Gerd Multhaup. The amyloid precursor protein and its homologues: structural and functional aspects of native and pathogenic oligomerization. European Journal of Cell Biology, 91(4):234–239, April 2012. URL: http://dx.doi.org/10.1016/j.ejcb.2011.01.017, doi:10.1016/j.ejcb.2011.01.017. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejcb.2011.01.017)

[13. (Zheng2006Theamyloidprecursorprotein:beyondamyloid) Hui Zheng and Edward H Koo. The amyloid precursor protein: beyond amyloid. Molecular Neurodegeneration, 1(1):5, 2006. URL: http://dx.doi.org/10.1186/1750-1326-1-5, doi:10.1186/1750-1326-1-5. This article has 639 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/1750-1326-1-5)

[14. (Di2009A) Giuseppe Di Fede, Marcella Catania, Michela Morbin, Giacomina Rossi, Silvia Suardi, Giulia Mazzoleni, Marco Merlin, Anna Rita Giovagnoli, Sara Prioni, Alessandra Erbetta, Chiara Falcone, Marco Gobbi, Laura Colombo, Antonio Bastone, Marten Beeg, Claudia Manzoni, Bruna Francescucci, Alberto Spagnoli, Laura Cantù, Elena Del Favero, Efrat Levy, Mario Salmona, and Fabrizio Tagliavini. A recessive mutation in the app gene with dominant-negative effect on amyloidogenesis. Science, 323(5920):1473–1477, March 2009. URL: http://dx.doi.org/10.1126/science.1168979, doi:10.1126/science.1168979. This article has 330 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.1168979)

[15. (Reinhard2005The) Constanze Reinhard, Sébastien S Hébert, and Bart De Strooper. The amyloid-β precursor protein: integrating structure with biological function: app: integrating structure with function. The EMBO Journal, 24(23):3996–4006, October 2005. URL: http://dx.doi.org/10.1038/sj.emboj.7600860, doi:10.1038/sj.emboj.7600860. This article has 206 citations.](https://doi.org/10.1038/sj.emboj.7600860)

[16. (Grabowski2001Novel) Thomas J. Grabowski, Hyun Soon Cho, Jean Paul G. Vonsattel, G. William Rebeck, and Steven M. Greenberg. Novel amyloid precursor protein mutation in an iowa family with dementia and severe cerebral amyloid angiopathy. Annals of Neurology, 49(6):697–705, 2001. URL: http://dx.doi.org/10.1002/ana.1009, doi:10.1002/ana.1009. This article has 421 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/ana.1009)

[17. (Coburger2014The) Ina Coburger, Sandra Hoefgen, and Manuel E. Than. The structural biology of the amyloid precursor protein app – a complex puzzle reveals its multi-domain architecture. Biological Chemistry, 395(5):485–498, February 2014. URL: http://dx.doi.org/10.1515/hsz-2013-0280, doi:10.1515/hsz-2013-0280. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/hsz-2013-0280)